STOCK TITAN
  1. Home
  2. Sec-filings
  3. ZYME
  4. [ARS] Zymeworks Inc. SEC Filing

[ARS] Zymeworks Inc. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Zymeworks Inc.

ARS Filing - Zymeworks Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: Zymeworks Inc. (ZYME)

Acceptance Date: 2025-11-10T16:31:24.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock ZYME logo
Zymeworks

NASDAQ:ZYME

ZYME Rankings

#2149 Ranked by Market Cap
N/A Ranked by Dividends

ZYME Latest News

Dec 2, 2025
Zymeworks Announces Participation in Upcoming Conferences
Nov 24, 2025
Zymeworks Announces Participation in Upcoming Investor Conferences
Nov 18, 2025
Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer
Nov 18, 2025
Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets
Nov 17, 2025
Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

ZYME Latest SEC Filings

Nov 18, 2025
[8-K] Zymeworks Inc. Reports Material Event
Nov 17, 2025
[8-K] Zymeworks Inc. Reports Material Event
Nov 10, 2025
[DEF 14A] Zymeworks Inc. Definitive Proxy Statement
Nov 6, 2025
[10-Q] Zymeworks Inc. Quarterly Earnings Report
Nov 6, 2025
[8-K] Zymeworks Inc. Reports Material Event

ZYME Stock Data

2.03B
72.09M
0.8%
101.5%
9.09%
Biotechnology
Pharmaceutical Preparations
Link
United States
MIDDLETOWN